GDTC · NASDAQ
CytoMed Therapeutics (GDTC) Stock Price & Fundamentals
CytoMed Therapeutics (GDTC) closed at $382.29 on Oct 9, 2026, down 0.79% from the previous close of $385.32.
Share price, past year
1Y +2.72%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $382.29 |
| Sep 30, 2026 | $378.31 |
| Aug 31, 2026 | $363.45 |
| Jul 31, 2026 | $364.08 |
| Jun 30, 2026 | $367.65 |
| May 29, 2026 | $381.15 |
| Apr 30, 2026 | $409.35 |
| Mar 31, 2026 | $403.08 |
| Feb 27, 2026 | $396.98 |
| Jan 30, 2026 | $372.76 |
| Dec 31, 2025 | $378.03 |
| Nov 28, 2025 | $383.26 |
| Oct 31, 2025 | $385.92 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 11.8M
- Dividend yield
- —
- 52-week range
- $358.05 – $416.41
Market cap, P/E and dividend yield aren't shown for CytoMed Therapeutics yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Singapore dollars.
Financials
CytoMed Therapeutics reported revenue of SGD 324.39K for fiscal 2025, up 366.74% from fiscal 2024.
Figures are in Singapore dollars (SGD), as CytoMed Therapeutics reports them to the SEC.
CytoMed Therapeutics reported a net loss of SGD 3.98M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | SGD 324.39K | +366.7% | −SGD 3.98M | −1,227.1% | −SGD 0.34 | −SGD 4.34M |
| FY2024ended Dec 31, 2024 | SGD 69.50K | — | −SGD 2.52M | −3,621.1% | −SGD 0.22 | −SGD 4.11M |
Company profile
- Name
- CytoMed Therapeutics Ltd
- Ticker
- GDTC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- #08-22 One Commonwealth, 1 Commonwealth Lane, U0 149544
- Incorporated in
- U0
- Fiscal year ends
- December
- SEC CIK
- 0001873093
Recent SEC filings
- Mar 31, 2026
- Apr 28, 2025
- Apr 22, 2024
- May 1, 2023
Frequently asked questions
What is CytoMed Therapeutics's stock price?
CytoMed Therapeutics (GDTC) closed at $382.29 on Oct 9, 2026, down 0.79% from the previous close of $385.32.
How much revenue does CytoMed Therapeutics make?
CytoMed Therapeutics reported revenue of SGD 324.39K for fiscal 2025, up 366.74% from fiscal 2024.
Sources and methodology
Fundamentals come from CytoMed Therapeutics Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures